Celanese Corp - Series A
Exchange: NYSESector: Basic MaterialsIndustry: Chemicals
Celanese is a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications. Our businesses use our chemistry, technology and commercial expertise to create value for our customers, employees and shareholders. We support sustainability by responsibly managing the materials we create and growing our portfolio of sustainable products to meet customer and societal demand. We strive to make a positive impact in our communities and to foster inclusivity across our teams. Celanese Corporation is a Fortune 500 company with more than 11,000 employees worldwide and 2024 net sales of $10.3 billion.
Did you know?
Earnings per share grew at a -4.9% CAGR.
Current Price
$64.06
+0.80%GoodMoat Value
$77.43
20.9% undervaluedProfile
Valuation (TTM)
Market Cap$7.01B
P/E-6.05
EV$17.75B
P/B1.73
Shares Out109.50M
P/Sales0.74
Revenue$9.54B
EV/EBITDA78.54
Celanese Corp - Series A (CE) Stock Analysis
GoodMoat Analysis
Celanese Corp is a chemical company currently priced at a significant discount to its GoodMoat target, but it presents a complex picture for value investors. The business shows a high free cash flow yield, yet its financials indicate severe profitability issues and high leverage. A thorough investigation requires reconciling the attractive valuation signal with the company's current operational and financial weaknesses.
Read full analysis
Celanese Corp operates in the chemicals industry, producing a range of acetyl and engineered materials. Applying the GoodMoat framework, the company's current financial data presents significant challenges for a traditional value analysis. Key quality indicators are weak: the company is not GAAP profitable, with a negative EPS of $-10.64 and an ROE of -28.6%. Revenue growth is negative at -6.5% YoY, and leverage is high with a Debt/Equity ratio of 3.18, far exceeding the favourable threshold of less than 1.0x. These metrics would likely result in multiple 'Weak' ratings in the Quality Indicators section, potentially causing the analysis to fail at Step 1 of the Decision Framework, which requires a Moat Score of at least 5 and predominantly 'Strong' quality ratings to proceed.
However, the valuation signal is compelling. The stock trades at $62.66 against a GoodMoat target of $77.43, implying a potential margin of safety of approximately 24%, which falls into the 'Favourable' band (20-40%) of the framework. Furthermore, the Free Cash Flow Yield is strong at 11.7%. For a value investor, this creates a tension: the price appears attractive, but the underlying business fundamentals are currently poor. The analysis hinges on whether the negative profitability is a temporary cyclical issue or a structural problem, and if the company's competitive advantages (its potential moat in areas like proprietary technology or scale in specific chemical segments) are durable enough to support a recovery. This discrepancy makes the company worth investigating further to understand the drivers behind the target price and the path to financial normalization.
Analysis based on data as of 2024-05-15.
Market Cap$7.01B
Current Price$64.06
P/E Ratio-6.05
Forward P/E—
PEG Ratio0.06
EPS$-10.64
Book Value$36.98
P/B Ratio1.73
CE Financial Charts
FCF vs CAPEX
FCFCAPEX
Forward estimates use -4.9% FCF growth (CAGR)
Cash vs Debt
Net Debt: 11.6B
Revenue
6.3B
FY19
5.7B
FY20
8.5B
FY21
9.7B
FY22
10.9B
FY23
10.3B
FY24
9.5B
FY25
Net Income
852M
FY19
2.0B
FY20
1.9B
FY21
1.9B
FY22
1.9B
FY23
—
FY24
—
FY25
CE 52-Week Range
$35.51
$65.77
50-Day MA: $54.52200-Day MA: $47.99
Did you know?
Free cash flow has been growing at -4.9% annually.
Celanese Corp - Series A (CE) Financial Summary
Celanese Corp - Series A (CE) is a Basic Materials company in the Chemicals industry, listed on NYSE. The stock currently trades at $64.06 with a market capitalization of $7.01B.
Key valuation metrics include a P/E ratio of -6.05, price-to-book ratio of 1.73, and EPS of $-10.64. The company reports a profit margin of -12.2% and return on equity of -28.6%.
CE Key Financial Metrics
| Metric | Value |
|---|---|
| Market Cap | $7.01B |
| P/E Ratio | -6.05 |
| EPS | $-10.64 |
| P/B Ratio | 1.73 |
| P/S Ratio | 0.74 |
| EV/EBITDA | 78.54 |
| Dividend Yield | 0.19% |
| Profit Margin | -12.2% |
| Return on Equity | -28.6% |
| Debt/Equity | 3.18 |
CE Revenue & Earnings History
| Year | Revenue | Net Income |
|---|---|---|
| FY19 | $6.30B | $852.00M |
| FY20 | $5.66B | $1.99B |
| FY21 | $8.54B | $1.89B |
| FY22 | $9.67B | $1.89B |
| FY23 | $10.93B | $1.94B |
| FY24 | $10.27B | $-1.54B |
| FY25 | $9.54B | $-1.17B |
Celanese Corp - Series A (CE) Valuation
Based on GoodMoat's DCF model, Celanese Corp - Series A has a fair value estimate of $77.43. At the current price of $64.06, the stock appears 17.3% undervalued relative to our intrinsic value estimate.
CE Quality Indicators
Celanese Corp - Series A maintains a profit margin of -12.2% and an operating margin of -8.6%. Return on equity stands at -28.6%. The current ratio is 1.55. Debt-to-equity ratio is 3.18.
About Celanese Corp - Series A
Celanese is a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications. Our businesses use our chemistry, technology and commercial expertise to create value for our customers, employees and shareholders. We support sustainability by responsibly managing the materials we create and growing our portfolio of sustainable products to meet customer and societal demand. We strive to make a positive impact in our communities and to foster inclusivity across our teams. Celanese Corporation is a Fortune 500 company with more than 11,000 employees worldwide and 2024 net sales of $10.3 billion.
CE Free Cash Flow
Celanese Corp - Series A generated $803.00M in trailing twelve-month free cash flow, representing an FCF yield of 11.45%. This strong FCF yield suggests the company generates substantial cash relative to its market value.
CE Shares Outstanding
Celanese Corp - Series A has 0.11 billion shares outstanding at a share price of $64.06, giving it a market capitalization of $7.01B.